BiologicsMD Inc’s recombinant fusion protein approach could show greater precision and fewer off-target effects while addressing latent unmet need in hair and bone conditions.
BiologicsMD Uses Unique Fusion Proteins To Treat Alopecia Safely
Emerging Company Profile: The US biotech is developing a series of recombinant fusion proteins to tackle alopecia and other diseases without supressing the immune system.
